Global Synthetic Oligonucleotides Supply, Demand and Key Producers, 2024-2030

Description

The global Synthetic Oligonucleotides market size is expected to reach $ 14230 million by 2030, rising at a market growth of 10.7% CAGR during the forecast period (2024-2030).

The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.

This report studies the global Synthetic Oligonucleotides demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Synthetic Oligonucleotides, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Synthetic Oligonucleotides that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Synthetic Oligonucleotides total market, 2019-2030, (USD Million)
Global Synthetic Oligonucleotides total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Synthetic Oligonucleotides total market, key domestic companies and share, (USD Million)
Global Synthetic Oligonucleotides revenue by player and market share 2019-2024, (USD Million)
Global Synthetic Oligonucleotides total market by Type, CAGR, 2019-2030, (USD Million)
Global Synthetic Oligonucleotides total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Synthetic Oligonucleotides market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Creative Biolabs, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., GE Healthcare, Kaneka Eurogentec S.A. and GeneDesign, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Synthetic Oligonucleotides market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Synthetic Oligonucleotides Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Synthetic Oligonucleotides Market, Segmentation by Type
    Column-Based Oligos
    Array-Based Oligos

Global Synthetic Oligonucleotides Market, Segmentation by Application
    Genetic Testing
    Pharmacy
    Other

Companies Profiled:
    Merck KGaA
    Thermo Fisher Scientific
    Creative Biolabs
    Danaher Corporation
    Eurofins Scientific SE
    Agilent Technologies, Inc.
    GE Healthcare
    Kaneka Eurogentec S.A.
    GeneDesign, Inc.
    LGC Biosearch Technologies
    Bio-synthesis Inc.
    GeneWorks Pty Ltd
    Integrated DNA Technologies, Inc
    BioAutomation
    Twist Bioscience

Key Questions Answered
1. How big is the global Synthetic Oligonucleotides market?
2. What is the demand of the global Synthetic Oligonucleotides market?
3. What is the year over year growth of the global Synthetic Oligonucleotides market?
4. What is the total value of the global Synthetic Oligonucleotides market?
5. Who are the major players in the global Synthetic Oligonucleotides market?

Table of Contents

1 Supply Summary
    1.1 Synthetic Oligonucleotides Introduction
    1.2 World Synthetic Oligonucleotides Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Synthetic Oligonucleotides Total Market by Region (by Headquarter Location)
        1.3.1 World Synthetic Oligonucleotides Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.3 China Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.4 Europe Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.5 Japan Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.6 South Korea Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.7 ASEAN Synthetic Oligonucleotides Market Size (2019-2030)
        1.3.8 India Synthetic Oligonucleotides Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Synthetic Oligonucleotides Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Synthetic Oligonucleotides Major Market Trends

2 Demand Summary
    2.1 World Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.2 World Synthetic Oligonucleotides Consumption Value by Region
        2.2.1 World Synthetic Oligonucleotides Consumption Value by Region (2019-2024)
        2.2.2 World Synthetic Oligonucleotides Consumption Value Forecast by Region (2025-2030)
    2.3 United States Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.4 China Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.5 Europe Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.6 Japan Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.7 South Korea Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.8 ASEAN Synthetic Oligonucleotides Consumption Value (2019-2030)
    2.9 India Synthetic Oligonucleotides Consumption Value (2019-2030)

3 World Synthetic Oligonucleotides Companies Competitive Analysis
    3.1 World Synthetic Oligonucleotides Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Synthetic Oligonucleotides Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Synthetic Oligonucleotides in 2023
        3.2.3 Global Concentration Ratios (CR8) for Synthetic Oligonucleotides in 2023
    3.3 Synthetic Oligonucleotides Company Evaluation Quadrant
    3.4 Synthetic Oligonucleotides Market: Overall Company Footprint Analysis
        3.4.1 Synthetic Oligonucleotides Market: Region Footprint
        3.4.2 Synthetic Oligonucleotides Market: Company Product Type Footprint
        3.4.3 Synthetic Oligonucleotides Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Synthetic Oligonucleotides Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Synthetic Oligonucleotides Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Synthetic Oligonucleotides Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Synthetic Oligonucleotides Consumption Value Comparison
        4.2.1 United States VS China: Synthetic Oligonucleotides Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Synthetic Oligonucleotides Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Synthetic Oligonucleotides Companies and Market Share, 2019-2024
        4.3.1 United States Based Synthetic Oligonucleotides Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Synthetic Oligonucleotides Revenue, (2019-2024)
    4.4 China Based Companies Synthetic Oligonucleotides Revenue and Market Share, 2019-2024
        4.4.1 China Based Synthetic Oligonucleotides Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Synthetic Oligonucleotides Revenue, (2019-2024)
    4.5 Rest of World Based Synthetic Oligonucleotides Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Synthetic Oligonucleotides Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Synthetic Oligonucleotides Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Synthetic Oligonucleotides Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Column-Based Oligos
        5.2.2 Array-Based Oligos
    5.3 Market Segment by Type
        5.3.1 World Synthetic Oligonucleotides Market Size by Type (2019-2024)
        5.3.2 World Synthetic Oligonucleotides Market Size by Type (2025-2030)
        5.3.3 World Synthetic Oligonucleotides Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Synthetic Oligonucleotides Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Genetic Testing
        6.2.2 Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Synthetic Oligonucleotides Market Size by Application (2019-2024)
        6.3.2 World Synthetic Oligonucleotides Market Size by Application (2025-2030)
        6.3.3 World Synthetic Oligonucleotides Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Merck KGaA
        7.1.1 Merck KGaA Details
        7.1.2 Merck KGaA Major Business
        7.1.3 Merck KGaA Synthetic Oligonucleotides Product and Services
        7.1.4 Merck KGaA Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Merck KGaA Recent Developments/Updates
        7.1.6 Merck KGaA Competitive Strengths & Weaknesses
    7.2 Thermo Fisher Scientific
        7.2.1 Thermo Fisher Scientific Details
        7.2.2 Thermo Fisher Scientific Major Business
        7.2.3 Thermo Fisher Scientific Synthetic Oligonucleotides Product and Services
        7.2.4 Thermo Fisher Scientific Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Thermo Fisher Scientific Recent Developments/Updates
        7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.3 Creative Biolabs
        7.3.1 Creative Biolabs Details
        7.3.2 Creative Biolabs Major Business
        7.3.3 Creative Biolabs Synthetic Oligonucleotides Product and Services
        7.3.4 Creative Biolabs Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Creative Biolabs Recent Developments/Updates
        7.3.6 Creative Biolabs Competitive Strengths & Weaknesses
    7.4 Danaher Corporation
        7.4.1 Danaher Corporation Details
        7.4.2 Danaher Corporation Major Business
        7.4.3 Danaher Corporation Synthetic Oligonucleotides Product and Services
        7.4.4 Danaher Corporation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Danaher Corporation Recent Developments/Updates
        7.4.6 Danaher Corporation Competitive Strengths & Weaknesses
    7.5 Eurofins Scientific SE
        7.5.1 Eurofins Scientific SE Details
        7.5.2 Eurofins Scientific SE Major Business
        7.5.3 Eurofins Scientific SE Synthetic Oligonucleotides Product and Services
        7.5.4 Eurofins Scientific SE Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Eurofins Scientific SE Recent Developments/Updates
        7.5.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
    7.6 Agilent Technologies, Inc.
        7.6.1 Agilent Technologies, Inc. Details
        7.6.2 Agilent Technologies, Inc. Major Business
        7.6.3 Agilent Technologies, Inc. Synthetic Oligonucleotides Product and Services
        7.6.4 Agilent Technologies, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Agilent Technologies, Inc. Recent Developments/Updates
        7.6.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    7.7 GE Healthcare
        7.7.1 GE Healthcare Details
        7.7.2 GE Healthcare Major Business
        7.7.3 GE Healthcare Synthetic Oligonucleotides Product and Services
        7.7.4 GE Healthcare Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 GE Healthcare Recent Developments/Updates
        7.7.6 GE Healthcare Competitive Strengths & Weaknesses
    7.8 Kaneka Eurogentec S.A.
        7.8.1 Kaneka Eurogentec S.A. Details
        7.8.2 Kaneka Eurogentec S.A. Major Business
        7.8.3 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product and Services
        7.8.4 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Kaneka Eurogentec S.A. Recent Developments/Updates
        7.8.6 Kaneka Eurogentec S.A. Competitive Strengths & Weaknesses
    7.9 GeneDesign, Inc.
        7.9.1 GeneDesign, Inc. Details
        7.9.2 GeneDesign, Inc. Major Business
        7.9.3 GeneDesign, Inc. Synthetic Oligonucleotides Product and Services
        7.9.4 GeneDesign, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 GeneDesign, Inc. Recent Developments/Updates
        7.9.6 GeneDesign, Inc. Competitive Strengths & Weaknesses
    7.10 LGC Biosearch Technologies
        7.10.1 LGC Biosearch Technologies Details
        7.10.2 LGC Biosearch Technologies Major Business
        7.10.3 LGC Biosearch Technologies Synthetic Oligonucleotides Product and Services
        7.10.4 LGC Biosearch Technologies Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 LGC Biosearch Technologies Recent Developments/Updates
        7.10.6 LGC Biosearch Technologies Competitive Strengths & Weaknesses
    7.11 Bio-synthesis Inc.
        7.11.1 Bio-synthesis Inc. Details
        7.11.2 Bio-synthesis Inc. Major Business
        7.11.3 Bio-synthesis Inc. Synthetic Oligonucleotides Product and Services
        7.11.4 Bio-synthesis Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Bio-synthesis Inc. Recent Developments/Updates
        7.11.6 Bio-synthesis Inc. Competitive Strengths & Weaknesses
    7.12 GeneWorks Pty Ltd
        7.12.1 GeneWorks Pty Ltd Details
        7.12.2 GeneWorks Pty Ltd Major Business
        7.12.3 GeneWorks Pty Ltd Synthetic Oligonucleotides Product and Services
        7.12.4 GeneWorks Pty Ltd Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 GeneWorks Pty Ltd Recent Developments/Updates
        7.12.6 GeneWorks Pty Ltd Competitive Strengths & Weaknesses
    7.13 Integrated DNA Technologies, Inc
        7.13.1 Integrated DNA Technologies, Inc Details
        7.13.2 Integrated DNA Technologies, Inc Major Business
        7.13.3 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product and Services
        7.13.4 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Integrated DNA Technologies, Inc Recent Developments/Updates
        7.13.6 Integrated DNA Technologies, Inc Competitive Strengths & Weaknesses
    7.14 BioAutomation
        7.14.1 BioAutomation Details
        7.14.2 BioAutomation Major Business
        7.14.3 BioAutomation Synthetic Oligonucleotides Product and Services
        7.14.4 BioAutomation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 BioAutomation Recent Developments/Updates
        7.14.6 BioAutomation Competitive Strengths & Weaknesses
    7.15 Twist Bioscience
        7.15.1 Twist Bioscience Details
        7.15.2 Twist Bioscience Major Business
        7.15.3 Twist Bioscience Synthetic Oligonucleotides Product and Services
        7.15.4 Twist Bioscience Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Twist Bioscience Recent Developments/Updates
        7.15.6 Twist Bioscience Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Synthetic Oligonucleotides Industry Chain
    8.2 Synthetic Oligonucleotides Upstream Analysis
    8.3 Synthetic Oligonucleotides Midstream Analysis
    8.4 Synthetic Oligonucleotides Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Synthetic Oligonucleotides Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Synthetic Oligonucleotides Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Synthetic Oligonucleotides Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Synthetic Oligonucleotides Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Synthetic Oligonucleotides Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Synthetic Oligonucleotides Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Synthetic Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Synthetic Oligonucleotides Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Synthetic Oligonucleotides Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Synthetic Oligonucleotides Players in 2023
    Table 12. World Synthetic Oligonucleotides Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Synthetic Oligonucleotides Company Evaluation Quadrant
    Table 14. Head Office of Key Synthetic Oligonucleotides Player
    Table 15. Synthetic Oligonucleotides Market: Company Product Type Footprint
    Table 16. Synthetic Oligonucleotides Market: Company Product Application Footprint
    Table 17. Synthetic Oligonucleotides Mergers & Acquisitions Activity
    Table 18. United States VS China Synthetic Oligonucleotides Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Synthetic Oligonucleotides Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Synthetic Oligonucleotides Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Synthetic Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Synthetic Oligonucleotides Revenue Market Share (2019-2024)
    Table 23. China Based Synthetic Oligonucleotides Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Synthetic Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Synthetic Oligonucleotides Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Synthetic Oligonucleotides Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Synthetic Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Synthetic Oligonucleotides Revenue Market Share (2019-2024)
    Table 29. World Synthetic Oligonucleotides Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Synthetic Oligonucleotides Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Synthetic Oligonucleotides Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Synthetic Oligonucleotides Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Synthetic Oligonucleotides Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Synthetic Oligonucleotides Market Size by Application (2025-2030) & (USD Million)
    Table 35. Merck KGaA Basic Information, Area Served and Competitors
    Table 36. Merck KGaA Major Business
    Table 37. Merck KGaA Synthetic Oligonucleotides Product and Services
    Table 38. Merck KGaA Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Merck KGaA Recent Developments/Updates
    Table 40. Merck KGaA Competitive Strengths & Weaknesses
    Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 42. Thermo Fisher Scientific Major Business
    Table 43. Thermo Fisher Scientific Synthetic Oligonucleotides Product and Services
    Table 44. Thermo Fisher Scientific Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Thermo Fisher Scientific Recent Developments/Updates
    Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 47. Creative Biolabs Basic Information, Area Served and Competitors
    Table 48. Creative Biolabs Major Business
    Table 49. Creative Biolabs Synthetic Oligonucleotides Product and Services
    Table 50. Creative Biolabs Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Creative Biolabs Recent Developments/Updates
    Table 52. Creative Biolabs Competitive Strengths & Weaknesses
    Table 53. Danaher Corporation Basic Information, Area Served and Competitors
    Table 54. Danaher Corporation Major Business
    Table 55. Danaher Corporation Synthetic Oligonucleotides Product and Services
    Table 56. Danaher Corporation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Danaher Corporation Recent Developments/Updates
    Table 58. Danaher Corporation Competitive Strengths & Weaknesses
    Table 59. Eurofins Scientific SE Basic Information, Area Served and Competitors
    Table 60. Eurofins Scientific SE Major Business
    Table 61. Eurofins Scientific SE Synthetic Oligonucleotides Product and Services
    Table 62. Eurofins Scientific SE Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Eurofins Scientific SE Recent Developments/Updates
    Table 64. Eurofins Scientific SE Competitive Strengths & Weaknesses
    Table 65. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
    Table 66. Agilent Technologies, Inc. Major Business
    Table 67. Agilent Technologies, Inc. Synthetic Oligonucleotides Product and Services
    Table 68. Agilent Technologies, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Agilent Technologies, Inc. Recent Developments/Updates
    Table 70. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    Table 71. GE Healthcare Basic Information, Area Served and Competitors
    Table 72. GE Healthcare Major Business
    Table 73. GE Healthcare Synthetic Oligonucleotides Product and Services
    Table 74. GE Healthcare Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. GE Healthcare Recent Developments/Updates
    Table 76. GE Healthcare Competitive Strengths & Weaknesses
    Table 77. Kaneka Eurogentec S.A. Basic Information, Area Served and Competitors
    Table 78. Kaneka Eurogentec S.A. Major Business
    Table 79. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product and Services
    Table 80. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Kaneka Eurogentec S.A. Recent Developments/Updates
    Table 82. Kaneka Eurogentec S.A. Competitive Strengths & Weaknesses
    Table 83. GeneDesign, Inc. Basic Information, Area Served and Competitors
    Table 84. GeneDesign, Inc. Major Business
    Table 85. GeneDesign, Inc. Synthetic Oligonucleotides Product and Services
    Table 86. GeneDesign, Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. GeneDesign, Inc. Recent Developments/Updates
    Table 88. GeneDesign, Inc. Competitive Strengths & Weaknesses
    Table 89. LGC Biosearch Technologies Basic Information, Area Served and Competitors
    Table 90. LGC Biosearch Technologies Major Business
    Table 91. LGC Biosearch Technologies Synthetic Oligonucleotides Product and Services
    Table 92. LGC Biosearch Technologies Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. LGC Biosearch Technologies Recent Developments/Updates
    Table 94. LGC Biosearch Technologies Competitive Strengths & Weaknesses
    Table 95. Bio-synthesis Inc. Basic Information, Area Served and Competitors
    Table 96. Bio-synthesis Inc. Major Business
    Table 97. Bio-synthesis Inc. Synthetic Oligonucleotides Product and Services
    Table 98. Bio-synthesis Inc. Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Bio-synthesis Inc. Recent Developments/Updates
    Table 100. Bio-synthesis Inc. Competitive Strengths & Weaknesses
    Table 101. GeneWorks Pty Ltd Basic Information, Area Served and Competitors
    Table 102. GeneWorks Pty Ltd Major Business
    Table 103. GeneWorks Pty Ltd Synthetic Oligonucleotides Product and Services
    Table 104. GeneWorks Pty Ltd Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. GeneWorks Pty Ltd Recent Developments/Updates
    Table 106. GeneWorks Pty Ltd Competitive Strengths & Weaknesses
    Table 107. Integrated DNA Technologies, Inc Basic Information, Area Served and Competitors
    Table 108. Integrated DNA Technologies, Inc Major Business
    Table 109. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product and Services
    Table 110. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Integrated DNA Technologies, Inc Recent Developments/Updates
    Table 112. Integrated DNA Technologies, Inc Competitive Strengths & Weaknesses
    Table 113. BioAutomation Basic Information, Area Served and Competitors
    Table 114. BioAutomation Major Business
    Table 115. BioAutomation Synthetic Oligonucleotides Product and Services
    Table 116. BioAutomation Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. BioAutomation Recent Developments/Updates
    Table 118. Twist Bioscience Basic Information, Area Served and Competitors
    Table 119. Twist Bioscience Major Business
    Table 120. Twist Bioscience Synthetic Oligonucleotides Product and Services
    Table 121. Twist Bioscience Synthetic Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 122. Global Key Players of Synthetic Oligonucleotides Upstream (Raw Materials)
    Table 123. Synthetic Oligonucleotides Typical Customers
List of Figure
    Figure 1. Synthetic Oligonucleotides Picture
    Figure 2. World Synthetic Oligonucleotides Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Synthetic Oligonucleotides Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Synthetic Oligonucleotides Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Synthetic Oligonucleotides Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Synthetic Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 13. Synthetic Oligonucleotides Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Synthetic Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Synthetic Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Synthetic Oligonucleotides by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Synthetic Oligonucleotides Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Synthetic Oligonucleotides Markets in 2023
    Figure 27. United States VS China: Synthetic Oligonucleotides Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Synthetic Oligonucleotides Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Synthetic Oligonucleotides Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Synthetic Oligonucleotides Market Size Market Share by Type in 2023
    Figure 31. Column-Based Oligos
    Figure 32. Array-Based Oligos
    Figure 33. World Synthetic Oligonucleotides Market Size Market Share by Type (2019-2030)
    Figure 34. World Synthetic Oligonucleotides Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Synthetic Oligonucleotides Market Size Market Share by Application in 2023
    Figure 36. Genetic Testing
    Figure 37. Pharmacy
    Figure 38. Other
    Figure 39. Synthetic Oligonucleotides Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience